Epinephrine vs Selective β2-Agonists in Adults or Children With Acute Asthma
What is the efficacy of epinephrine vs selective β2-agonists in children and adults with acute asthma, and what is their combined efficacy?
What is the efficacy of epinephrine vs selective β2-agonists in children and adults with acute asthma, and what is their combined efficacy?
Is omalizumab equally efficacious in treating allergic asthma among children from varying racial/ethnic backgrounds?
CHRONICLE investigators reported results of a patient survey on common asthma triggers at ACAAI 2021.
The SINUS-24/52 trial evaluated dupilumab’s impact on CRSwNP and comorbid asthma, looking at baseline asthma characteristics.
In CHRONICLE, researchers examined associations between exacerbations and initiation of biologic therapy in patients with uncontrolled severe asthma.
Research presented at ACAAI 2021 evaluated the efficacy of different biologic therapies in controlling asthma exacerbations in patients with varying BECs.
In children with asthma, is excess weight linked to dysanapsis and PAI — and how do all 3 factors affect the risk of uncontrolled asthma?
Investigators assessed the relationship between passive smoking in children and adults with adult risk for fatty liver.
What did the SANDMAN trial find — and could a chemically altered follow-up to BAY 2253651 fill the void of pharmacological agents for treating OSA?
Is asthma triple therapy with umeclidinium plus fluticasone furoate/vilanterol effective for patients with uncontrolled asthma who overuse SABA as rescue therapy?